NAROPIN
NAROPIN
Approved
DIN Number
02229418
Drug Class
Human
Market Date
Apr 14, 1997
Company
HC
Aspen Pharmacare Canada Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02229418
AIG Number0133273005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
N01BB09 ROPIVACAINE
Product Specifications
Dosage FormSolution
Route of AdministrationEpidural
AHFS Classification72:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ROPIVACAINE HYDROCHLORIDEActive
Strength: 10 MG / ML
Monograph: ROPIVACAINE HYDROCHLORIDE